Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound.
Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound.
复制标题
尿激酶的不溶性衍生物激活人纤溶酶原。
DOI:
10.1111/j.1432-1033.1973.tb02880.x
复制
发表时间:
1973
期刊:
影响因子:
--
通讯作者:
P. Wallén
中科院分区:
文献类型:
--
作者:
B. Wiman;P. Wallén
Activation of plasminogen was performed by perfusing a plasminogen solution through a small column loaded with insolubilized urokinase. The effluent was immediately collected in an excess of plasmin inhibitor (p-nitrophenyl-p-guanidino-benzoate). This provides a practically instantaneous inhibition of the plasmin formed and autocatalytic degradation is thus reduced to a minimum. Different degrees of activation are obtained by changing the perfusion rate.
Dodecylsulfate-polyacrylamide electrophoresis, amino acid and NH2-terminal amino acid analyses show that the activation of human plasminogen involves cleavage of at least two peptide bonds, the first event being the release of a peptide of 64 amino acid residues from the NH2-terminal end. An intermediate inactive product with a molecular weight of about 86000 and methionine as NH2-terminal amino acid is formed. Cleavage at the second site results in formation of a molecule with two chains connected by disulfide bridges. One chain which has a molecular weight of about 63000 is very sensitive to proteolytic degradation in its NH2-terminal part. However, there is evidence that methionine is the true NH2-terminal amino acid of this fragment. The other chain has a molecular weight of about 25000 and has valine as NH2-terminal amino acid.